These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29941885)

  • 1. Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia.
    Rosenberg A; Ene IV; Bibi M; Zakin S; Segal ES; Ziv N; Dahan AM; Colombo AL; Bennett RJ; Berman J
    Nat Commun; 2018 Jun; 9(1):2470. PubMed ID: 29941885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the fluconazole trailing effect on the persistence of Candida albicans bloodstream infection when treated with fluconazole.
    Lin SY; Huang HY; Chang LL; Wang YL; Chen TC; Chang K; Tu HP; Lu PL
    Clin Microbiol Infect; 2024 Jul; 30(7):945-950. PubMed ID: 38527614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility of Candida albicans blood isolates to 3 antifungal drugs: retrospective study in Rio Grande do Sul, Brazil, 1999-2009].
    Mattei AS; Alves SH; Mario DA; Watte G; Severo CB; Guazzelli Lda S; Oliveira Fde M; Severo LC
    Rev Iberoam Micol; 2013; 30(4):243-7. PubMed ID: 23500157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital.
    Peron IH; Reichert-Lima F; Busso-Lopes AF; Nagasako CK; Lyra L; Moretti ML; Schreiber AZ
    PLoS One; 2016; 11(7):e0158126. PubMed ID: 27414653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal Tolerance and Resistance Emerge at Distinct Drug Concentrations and Rely upon Different Aneuploid Chromosomes.
    Yang F; Scopel EFC; Li H; Sun LL; Kawar N; Cao YB; Jiang YY; Berman J
    mBio; 2023 Apr; 14(2):e0022723. PubMed ID: 36877011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy.
    Zhang L; Xiao M; Watts MR; Wang H; Fan X; Kong F; Xu YC
    BMC Infect Dis; 2015 Aug; 15():340. PubMed ID: 26282840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Gerstein AC; Berman J
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates.
    Marcos-Zambrano LJ; Escribano P; Sánchez-Carrillo C; Bouza E; Guinea J
    Med Mycol; 2016 Oct; 54(7):733-9. PubMed ID: 27161788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. diskImageR: quantification of resistance and tolerance to antimicrobial drugs using disk diffusion assays.
    Gerstein AC; Rosenberg A; Hecht I; Berman J
    Microbiology (Reading); 2016 Jul; 162(7):1059-1068. PubMed ID: 27126388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant
    Xu Y; Quan H; Wang Y; Zhong H; Sun J; Xu J; Jia N; Jiang Y
    Front Cell Infect Microbiol; 2017; 7():491. PubMed ID: 29238700
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
    Zhang X; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):279-84. PubMed ID: 27116986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z; Sobel JD
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
    Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
    Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
    Khajeh E; Hosseini Shokouh SJ; Rajabibazl M; Roudbary M; Rafiei S; Aslani P; Farahnejad Z
    Br J Biomed Sci; 2016; 73(1):44-8. PubMed ID: 27182677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
    PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.